Autologous transfusion of stored red blood cells increases pulmonary artery pressure

Am J Respir Crit Care Med. 2014 Oct 1;190(7):800-7. doi: 10.1164/rccm.201405-0850OC.

Abstract

Rationale: Transfusion of erythrocytes stored for prolonged periods is associated with increased mortality. Erythrocytes undergo hemolysis during storage and after transfusion. Plasma hemoglobin scavenges endogenous nitric oxide leading to systemic and pulmonary vasoconstriction.

Objectives: We hypothesized that transfusion of autologous blood stored for 40 days would increase the pulmonary artery pressure in volunteers with endothelial dysfunction (impaired endothelial production of nitric oxide). We also tested whether breathing nitric oxide before and during transfusion could prevent the increase of pulmonary artery pressure.

Methods: Fourteen obese adults with endothelial dysfunction were enrolled in a randomized crossover study of transfusing autologous, leukoreduced blood stored for either 3 or 40 days. Volunteers were transfused with 3-day blood, 40-day blood, and 40-day blood while breathing 80 ppm nitric oxide.

Measurements and main results: The age of volunteers was 41 ± 4 years (mean ± SEM), and their body mass index was 33.4 ± 1.3 kg/m(2). Plasma hemoglobin concentrations increased after transfusion with 40-day and 40-day plus nitric oxide blood but not after transfusing 3-day blood. Mean pulmonary artery pressure, estimated by transthoracic echocardiography, increased after transfusing 40-day blood (18 ± 2 to 23 ± 2 mm Hg; P < 0.05) but did not change after transfusing 3-day blood (17 ± 2 to 18 ± 2 mm Hg; P = 0.5). Breathing nitric oxide decreased pulmonary artery pressure in volunteers transfused with 40-day blood (17 ± 2 to 12 ± 1 mm Hg; P < 0.05).

Conclusions: Transfusion of autologous leukoreduced blood stored for 40 days was associated with increased plasma hemoglobin levels and increased pulmonary artery pressure. Breathing nitric oxide prevents the increase of pulmonary artery pressure produced by transfusing stored blood. Clinical trial registered with www.clinicaltrials.gov (NCT 01529502).

Trial registration: ClinicalTrials.gov NCT01529502.

Keywords: echocardiography; endothelium; hemoglobins; nitric oxide; pulmonary hypertension.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adult
  • Blood Pressure / drug effects*
  • Blood Transfusion, Autologous / adverse effects*
  • Blood Transfusion, Autologous / methods
  • Bronchodilator Agents / administration & dosage
  • Bronchodilator Agents / pharmacology
  • Cross-Over Studies
  • Erythrocyte Transfusion / adverse effects*
  • Erythrocyte Transfusion / methods
  • Female
  • Humans
  • Hypertension, Pulmonary / etiology*
  • Male
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / pharmacology
  • Obesity / complications
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / physiopathology*
  • Time Factors
  • Vasoconstriction / drug effects

Substances

  • Bronchodilator Agents
  • Nitric Oxide

Associated data

  • ClinicalTrials.gov/NCT01529502